Quercetin as a therapeutic agent activate the Nrf2/Keap1 pathway to alleviate lung ischemia-reperfusion injury
Scientific Reports · 04.10.2024 · 14 (1)
DOI: 10.1038/s41598-024-73075-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 04.10.2024. Verfasst von Mohammad Yousefi Zardak und 18 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, NF-E2-Related Factor 2, Oxidative Stress, Quercetin. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kerman University of Medical Sciences.
Abstract (Originalsprache)
Lung ischemia-reperfusion injury (LIRI) causes oxidative stress, inflammation, and immune system activation. The Nrf2/Keap1/HO-1 pathway is important in cellular defense against these effects. Quercetin, a flavonoid with antioxidant, anti-inflammatory, and anti-cancer properties, has been investigated. Our aim in this study was to investigate the effect of quercetin on preventing lung ischemia-reperfusion injury and the role of the Nrf2/Keap1/HO-1 pathway. Sixty-four male Wistar rats were divided into four distinct groups( n = 16). Sham, lung ischemia-reperfusion (LIR), Saline + LIR, Quercetin + LIR (30 mg/kg i.p for a week before LIR). LIR groups were subjected to 60 min of ischemia (left pulmonary artery, vein, and bronchus) and 120 min of reperfusion. Our assessment encompassed a comprehensive analysis of various factors, including the evaluation of expression Nrf2, Keap1, and Heme Oxygenase-1 (HO-1) levels and NF-κB protein. Furthermore, we examined markers related to inflammation (interleukin-1β and tumor necrosis factor alpha), oxidative stress (malondialdehyde, total oxidant status, superoxide dismutase, glutathione peroxidase, total antioxidant capacity), lung edema (Wet/dry lung weight ratio and total protein concentration), apoptosis (Bax and Bcl2 protein), and histopathological alterations (intra-alveolar edema, alveolar hemorrhage, and neutrophil infiltration). Our results show that ischemia-reperfusion results in heightened inflammation, oxidative stress, apoptosis, lung edema, and histopathological damage. Quercetin showed preventive effects by reducing these markers, acting through modulation of the Nrf2/Keap1 pathway and inhibiting the NF-κB pathway. This anti-inflammatory effect, complementary to the antioxidant effects of quercetin, provides a multifaceted approach to cell protection that is important for developing therapeutic strategies against ischemia-reperfusion injury and could be helpful in preventive strategies against ischemia-reperfusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
- Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
- Department of Exercise Physiology, Faculty of Physical Education, Shahid Bahonar University, Kerman, Iran.
- Department of Physiology and Pharmacology, Afzalipour Medical Faculty, Kerman University of Medical Sciences, Kerman, Iran.
- Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran.
- Noncommunicable Diseases Research center, Bam University of Medical Sciences, Bam, Kerman, Iran.
Förderung
- Kerman University of Medical Sciences
Zitieren
APA
Yousefi Zardak, M., Keshavarz, F., Mahyaei, A., Gholami, M., Moosavi, F. S., Abbasloo, E., Abdollahi, F., Hossein Rezaei, M., Madadizadeh, E., Soltani, N., Bejeshk, F., Salehi, N., Rostamabadi, F., Bagheri, F., Jafaraghae, M., Ranjbar Zeydabadi, M., Baghgoli, M., Sepehri, G., & Bejeshk, M. A. (2024). Quercetin as a therapeutic agent activate the Nrf2/Keap1 pathway to alleviate lung ischemia-reperfusion injury. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-73075-7
Vancouver
Yousefi Zardak M, Keshavarz F, Mahyaei A, Gholami M, Moosavi FS, Abbasloo E, et al. Quercetin as a therapeutic agent activate the Nrf2/Keap1 pathway to alleviate lung ischemia-reperfusion injury. Scientific Reports. 2024;14(1). doi:10.1038/s41598-024-73075-7
BibTeX
@article{YousefiZardak2024,
author = {Yousefi Zardak, Mohammad and Keshavarz, Fatemeh and Mahyaei, Ali and Gholami, Morteza and Moosavi, Fatemeh Sadat and Abbasloo, Elham and Abdollahi, Farzaneh and Hossein Rezaei, Maryam and Madadizadeh, Elham and Soltani, Nasrin and Bejeshk, Fatemeh and Salehi, Niyan and Rostamabadi, Fahimeh and Bagheri, Fatemeh and Jafaraghae, Mahla and Ranjbar Zeydabadi, Mahdiyeh and Baghgoli, Meraj and Sepehri, Gholamreza and Bejeshk, Mohammad Abbas},
title = {Quercetin as a therapeutic agent activate the Nrf2/Keap1 pathway to alleviate lung ischemia-reperfusion injury},
journal = {Scientific Reports},
year = {2024},
volume = {14},
number = {1},
doi = {10.1038/s41598-024-73075-7}
}
EUVIMED